Hyperparathyroidism Disease

BASICS

DESCRIPTION

Hyperparathyroidism represents a loss in control of the body's normal regulatory feedback mechanism on the parathyroid glands and their ability to maintain a normal serum calcium

  • Primary hyperparathyroidism - direct hyperfunction of the parathyroid glands due to either glandular hyperplasia or adenoma
  • Secondary hyperparathyroidism - usually found in chronic renal disease or vitamin D deficient states which cause hyperplasia of all four glands and associated increase in activity
  • Multiple endocrine neoplasia (MEN syndromes) - disease states with associated endocrine malfunctions with parathyroid gland hyperplasia leading to a hyperparathyroid state
  • Parathyroid carcinoma - extremely rare
  • System(s) affected: Endocrine/Metabolic
  • Genetics: N/A
  • Incidence/Prevalence in USA:
    • Rare in children
    • Male adults 60 years or older - 100 cases/100,000
    • Female adults 60 years or older - 300-400 cases/100,000
    • All-age adjusted incidence - 42 cases/100,000
    • Prevalence all ages - 250 cases/100,000 population
  • Predominant age: Age greater than 50
  • Predominant sex: Females > Males (4:1)
SIGNS AND SYMPTOMS
  • "Painful bones, renal stones, abdominal groans and psychic moans." You must think of it to diagnose it.
  • Renal:
    • Nephrolithiasis
    • Nephrocalcinosis
    • Reduced glomerular filtration rate
    • Thirst
    • Polydipsia
    • Polyuria
  • Gastrointestinal:
    • Abdominal distress
    • Gastroduodenal ulcer
    • Pancreatitis
    • Pancreatic calcification
    • Constipation
    • Vomiting
    • Anorexia
    • Weight loss
  • Skeletal:
    • Bone pain and tenderness
    • Cystic bone lesions
    • Skeletal demineralization
    • Spontaneous fracture
    • Vertebral collapse
    • Osteoporosis
  • Mental:
    • Fatigue
    • Apathy
    • Anxiety
    • Depression
    • Psychosis
  • Neurologic:
    • Somnolence
    • Coma
    • Diffuse EEG abnormalities
  • Neuromuscular:
    • Muscle fatigue
    • Weakness
    • Hypotonia
  • Cardiovascular:
    • Hypertension
    • Short QT interval
  • Articular/periarticular:
    • Arthralgia
    • Gout
    • Pseudogout
    • Periarticular calcification
  • Ocular:
    • Band keratopathy
    • Conjunctivitis
    • Conjunctival calcium deposits
CAUSES
  • Primary hyperparathyroidism
    • Caused by usually one but sometimes multiple parathyroid gland hyperplasia or adenomatous changes which cause an unregulated increase of parathyroid hormone (PTH) production and release, causing increase in serum calcium
  • Secondary hyperparathyroidism
    • Seen most often in chronic renal failure because of adaptive parathyroid gland hyperplasia and hyperfunction
    • Renal parenchymal loss resulting in hyperphosphatemia
    • Impaired calcitriol production leading to hypocalcemia
    • General skeletal and renal resistance to PTH for reasons unknown
RISK FACTORS
  • Age greater than 50
  • Female
  • Occurs more frequently in temperate than tropical climates
  • Higher incidence in people exposed to therapeutic low dose radiation

DIAGNOSIS

LABORATORY
  • Elevated serum calcium greater than 10.2 mg/dL (2.55 mmol/L) on 3 successive measurements
  • Elevated serum immunoreactive parathyroid hormone (iPTH) levels
  • Low serum phosphate levels, less than 2.5 mg/dL (0.81 mmol/L)
  • Elevated serum chloride levels
  • Decreased serum CO2
  • Hyperchloremic metabolic acidosis
  • Increase in urinary cyclic AMP

Drugs that may alter lab results: N/A
Disorders that may alter lab results: N/A

PATHOLOGICAL FINDINGS
  • Parathyroid hyperplasia - all parathyroid glands with cellular changes
  • Parathyroid adenoma - only one gland usually with cellular changes
  • Parathyroid carcinoma - cellular changes consistent with malignancy, i.e., cellular atypia, lymph node changes
SPECIAL TESTS
Immunoassay directed against intact PTH molecule
IMAGING
  • Neck ultrasonography
  • Thallium technetium scanning
  • Magnetic resonance imaging
  • CT scanning with and without contrast
  • Sestamibi scan for neck
DIAGNOSTIC PROCEDURES
  • Percutaneous needle biopsy aspiration for cytology and PTH determination
  • Open surgical removal with frozen section diagnosis

TREATMENT

APPROPRIATE HEALTH CARE

Outpatient usually. Inpatient for surgery or for treatment of underlying cause.

GENERAL MEASURES
  • A few patients with mild asymptomatic hypercalcemia due to hyperparathyroidism may not be candidates for surgery and may be managed conservatively. Avoiding dehydration is the most important treatment.
SURGICAL MEASURES
  • Surgical removal of diseased gland is only proven curative therapy for hyperparathyroidism (subtotal resection)
  • In preoperative and immediately postoperative patients, large fluid intake is indicated to help prevent formation of renal stones
  • Open neck surgical exploration advocated approach
  • Removal of obviously diseased gland with biopsies of other glands to make sure physiologically viable
  • Total resection of all four glands with transplantation of normal gland to forearm advocated by some
  • Special attention must be made during exploration and removal of parathyroid glands for ectopic gland in the neck area
  • Postoperative course needs special attention paid to airway and risk of airway compromise
  • Monitoring renal functions closely
ACTIVITY

As tolerated

DIET

As indicated by condition of patient

PATIENT EDUCATION
  • Educate about medications
  • Importance of periodic lab exams

FOLLOW UP

PREVENTION/AVOIDANCE

N/A

POSSIBLE COMPLICATIONS
  • Skeletal damage (pathologic fractures)
  • Renal damage
  • Urinary tract infections
  • "Parathyroid poisoning"
  • Hypertension
  • From surgery:
    • Hypoparathyroidism
    • Recurrent laryngeal nerve damage
    • Bleeding
    • Infection
    • Unsuccessful surgery (5%)
EXPECTED COURSE AND PROGNOSIS
  • Postoperative course requires following of serum calcium to make sure hyperparathyroid state does not redevelop
  • Prognosis is excellent in primary hyperparathyroidism with resolution of many of the preoperative symptoms
  • Secondary hyperparathyroidism carries a poor prognosis because of the primary disease state of chronic renal failure

MISCELLANEOUS

ASSOCIATED CONDITIONS

Multiple endocrine neoplasia (MEN) syndromes

AGE-RELATED FACTORS

Pediatric: N/A
Geriatric:

  • Common in the elderly
  • More likely to have a secondary disease
  • May cause confusion and be interpreted as senile dementia

Others: N/A

PREGNANCY

Rarely occurs during pregnancy

OTHER NOTES

N/A

ABBREVIATIONS

PTH = parathyroid hormone

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.